We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi gixer,
Great find. Wonderful detective work. If you have a contact e-mail address of our good friend IF please send all these links so that he could include all these great research in PXS website.
This is another.
"Effect of tomato, lycopene and related products on blood pressure: A systematic review and network meta-analysis"
"Subgroup analysis in hypertensive patients showed that STE significantly reduced both SBP and DBP with pooled MDs (95% CIs) of –8.09 (–11.52 to –4.67) and –4.25 (–6.97 to –1.53) mmHg, respectively, compared to placebo. Other forms of tomato, including other dose ranges of standardized tomato extract, tomato-containing diet, lycopene-free preparation, and synthetic lycopene, did not show consistent and significant effects on either SBP or DBP in all analyses.
Conclusion
Standardized tomato extract (STE) significantly decreased SBP compared to placebo in a mixed population of healthy volunteers and hypertensive patients. The BP-lowering effect was more pronounced among hypertensive patients. No significant BP effects were seen with other forms of tomato, lycopene and related products in the overall population or any subgroup of the population.
https://www.sciencedirect.com/science/article/abs/pii/S0944711321000544
Not just the Chinese that are doing studies.......
Fruitflow is included in this Pharmacological Research Review but unfortunately its a pay to view.
"The current use and evolving landscape of nutraceuticals"
https://www.sciencedirect.com/science/article/abs/pii/S1043661821005855#!
A google search brings up.....
The Current Use and Evolving Landscape of Nutraceuticalshttps://www.sciencedirect.com › science › article › pii
5 days ago — One such example of a successful product is Fruitflow® manufactured by Provexis. ... ScienceDirect ® is a registered trademark of Elsevier B.V..
"The "big health era" is coming,
that is a big balls brassy statement , didn't get one of those from DSM post EU13
As you can see, it was only set up in May last year.
https://www.ltddir.com/companies/byhealth-international-company-limited/
Top spot ? During this year's Double 11, BYHEALTH retained its top spot on Alibaba and JD’s VDS charts in China. Sales of RMB$600m (US$93.9m) were achieved, which was 38.3 per cent more than last year. “BYHEALTH International range has achieved amazing results as well, with about 200 per cent yoy growth in GMV as compared to last year’s Double 11,” ?she said. There are currently 10 to 15 SKUs in the BYHEALTH international range, with the products manufactured in the United States or Australia. These products are sold into China via cross-border e-commerce (CBEC) through Tmall, JD, and are also stocked in Chemist Warehouse outlets in China. Gu revealed that about 70 per cent of the international products sales came from China – making China a key focus at the moment. The remaining sales are from Hong Kong, Australia, New Zealand, and Singapore – which the brand only entered in August this year.? In contrast to China, the more popular products in Hong Kong are its collagen gummies and iron sachet powder.
NPD directions ? Gu said that BYHEALTH International would be exploring immune, cardiovascular, and men’s health as part of its new product development. “Interestingly, categories such as immune enhancement and cardiovascular protection have also increased by around 16 per cent in the past year,” ?she said. BYHEALTH recently entered into a partnership with UK company Provexis which has developed a proprietary heart health functional food ingredient known as Fruitflow. Under the agreement, BYHEALTH would manufacture, market, and sell functional food and dietary supplements containing the ingredient in Mainland China, Hong Kong, Macau, Taiwan, and Australia. The agreement will take full effect from Jan 1, 2023.
"Gu said that BYHEALTH International would be exploring immune, cardiovascular, and men’s health as part of its new product development."
FWIW "BYHEALTH International" is a Hong Kong registered company that appears to be for cross border products.
https://www.nutraingredients-asia.com/Article/2021/11/29/For-the-night-owl-BYHEALTH-reports-strong-sales-of-milk-thistle-melatonin-products-in-11.11?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
I know we know and you know that ,but surely the point is that potential customers are unaware
Another article on the benefits of Fruitflow published in China.
Like the previous articles it is published twice with the only difference appearing to be the headline.
"The "big health era" is coming, what effect does Xinluoxin water-soluble tomato concentrate have on platelet aggregation?"
https://tech.ifeng.com/c/8BU6OGzxTd8
"Xinluoxin water-soluble tomato concentrate is available, how does it help to inhibit platelet aggregation?"
https://tech.ifeng.com/c/8BSvjsESN1e
The articles get published on multiple sites and all reference By-Health Institute of Nutrition and Health but I cannot find out if it is them that is behind them.
Yes we know that , so the ? is will BH be forking out lots on advertising? the gurus on here think they will after all the expense of getting Blue status . Which is just like EU13 !!! ROTF-PMSL. Not a matter of keeping the faith but just keeping the shares.
Product is too expensive ,dificult to get hold of in the high street.Very few people who would benefit from FF have never heard of it.Over to you Bod.
Lots of interesting stuff on there . Dr H
WS I haven't managed to get anyone on FF even after giving them some free. I find it amazing that people will not try and improve their health the easiest way by taking a pill.
The blue table halfway down tells a bit.
https://daxueconsulting.com/vitamins-dietary-supplements-china/
Everhopeful, It was launched April 2020. Not sure you could class that as new.
"however never think that it will be them that needs to get a precautionary supplement in their older age"
The thing about FF is that its benefits are tangible. From experience I know some who take it purely because it stops them nodding off mid afternoon at work, and others because their feet are no longer cold. They wouldn't be without it
The trick is to get people to try it so they can see the benefit themselves.
Smaller packs (7?) might be easier to temp people to try.
I'm ambivalent re DSM, on one hand the patents weren't in place, on the other if they wanted to they could have put FF logo on Team DSM shirt (where there's a will....).
W$
Look at SIS with its circa £1m
that is where Moon was clever he knew competitive people would always be looking for a edge . Most however never think that it will be them that needs to get a precautionary supplement in their older age .
Thanks Gixer , I didn't look under Traditional products because it isn't traditional it is new.
Cobalt,
It will be more than 3p for sure. Look at SIS with its circa £1m profit. That is worth circa £95m at present and was worth more. That is around 5 times PXS market cap.
I am hoping that once BH get started with their own BH products and distribution, it will bring in some proper money. I think it will certainly make big news!! We’ve seen how wide spread the notice of the PXS collaboration went.
The next couple of years will be interesting. Who knows, one day I may even get my money back :)
Everhopeful??????
https://www.biogrow.com.my/products/botanical-supplements/smoflo-capsule
Much as I'd love to make a case for the defence here colbaltblue, like other posters I have to agree with much of what you've said. I'm pretty sure it pains you as much as the rest of us but the facts speak for themselves. I know DSM from a previous life, they are HUGE in their field and so when the tie-up was announced it filled me with confidence. The reality has been massive disappointment and unfulfilled promise. I still firmly believe in the science here which surely must deliver sooner or later. Whether I'll live long enough to see it is another matter. Until then, no doubt we'll have more promises of "multiples" of existing volume...
Now if there was a FF Futures market !
CB is probably right Re time line ,but I hope for a early TO , 3p would be fine ( to think I used to hope for 30p ! )
Boring Bernie is right , H&B is like Health plan which is where I get my FF , FF does not feature FF in their pamphlet , they dont waste money on ink if they can help it .
There will probably be another 3 fund raises before PXS makes enough to pay the BODs their un earnt over inflated salaries.
The SmoFlow product isn't even on their website in Malaysia so either they don't have any or it is withdrawn? , you can't go by websites anyone can make a web page in 5 mins .
https://www.biogrow.com.my/
CB does have one valid point, there will be a fund raise later 2022 to buy a load of Fruitflow to sell to B-Health. But that money raised will be more than worth it. Yes a lot of posters on here knocking the share but dont have any. Some even think they will be buying at 0.25 lol
colbaltblue, no wonder you are depressed if those are your views. That is if you are still a holder here and not just knocking for knocking sake like certain others that will remain nameless.
I do partially agree with you on one point though and although we have much to be thankful to DSM for I do believe that they could have/could do more. If they had been as proactive as By-Health is proving to be now then things may have been totally different here. So, if it takes By-Health to kickstart the other majors/globals then so be it.
Overview of BH results.
https://www.nutraingredients-asia.com/Article/2021/08/10/BY-HEALTH-half-year-results-Revenue-from-online-direct-sales-stores-soaring-for-China-giant
2010 this was 20p history might repeat itself
If you take the view that any future value is in the hands of the PRC, it all becomes rather depressing. This is now a one trick Pony with all the chips put on success in China. Maybe 2024 will be the start of meaningful income so probably nothing of any consequence until 2024/2025. Then what? A three bag to 3p? But the skill will be in avoiding the mass exodus to the exit door of folk who have been invested/stuck (by 2025) for nearly FIFTEEN YEARS!! Just let that thought sink in for a minute. 15 years and the SP is less than one penny. Too much blind optimism, lack of shareholder involvement and faith in a company which has simply not delivered. Let's hope that the actual product continues to be available in the future despite the very poor way it has been managed (IMO) Does anyone believe the 2010 collaboration with DSM has been any thing other than an extremely modest outcome and way below expectations?
Plenty of other ways to multibag on AIM.
When's the next fundraise?